Demonising Justin Gatlin
13th September 2015
• The Danish women’s team will take the field against Croatia in tomorrow’s Women’s World Cup qualifier, after the Danish football association (DBU) and the Danish players association (Spillerforeningen) came to a temporary agreement on remuneration. ‘The DBU and the players association have signed a partial agreement that ensures the important match will take place’, read a joint statement, published on both the DBU and Spillerforeningen internet sites. ‘The parties have agreed that negotiations will continue immediately after the Croatia match. FIFPro and UEFA will also join as mediators for a new national team agreement.’ The DBU and Spillerforeningen said that they had not been notified about any sanctions due to the cancellation of Friday’s match against Sweden.
• The US Anti-Doping Agency (USADA) has informed Antonio Rogerio Nogueira of an adverse analytical finding (AAF) resulting from a sample collected on 27 September. ‘Due to the proximity of Nogueira’s upcoming scheduled bout at UFC FIGHT NIGHT: LAWLER vs. DOS ANJOS in Winnipeg, Canada on December 16, 2017 against Jared Cannonier, Nogueira has been removed from the card and the UFC is currently seeking a replacement’, read a statement, from the Ultimate Fighting Championship (UFC).
• A cyclist drafted in by the Bardiani-CSF team to replace Nicola Ruffoni and Stefano Pirazzi, who tested positive for growth hormone releasing peptides (GHRPs) in April, has blamed a positive test for furosemide on his mother’s medication. Michael Bresciani claims that his mother’s Lasix medication must have slipped into his food during meal preparation, reports CyclingNews. Italian tennis player Sara Errani was sanctioned with a two month ban, after her explanation that an adverse analytical finding (AAF) for letrozole was caused by her mother’s breast cancer medication dropping into her food was accepted.
Researchers at the University of Waterloo in Canada have developed a drug test that they...
Integrity officers from football’s regulatory bodies will convene at the Chelsea Harbour Hotel in London...